10 Jun 2015 07:00
Immunodiagnostic Systems Holdings plc
Board Appointment
10 June 2015
Immunodiagnostic Systems Holdings plc ("IDS" or "the Company" or "the Group"), a leading solution provider to the clinical laboratory diagnostic market, is pleased to announce that Peter John Williamson, aged 49, will join the Board of IDS as a Non-Executive Director with effect from 15 June 2015.
Peter holds a Master of Business Administration from the University of Edinburgh. Between 1993 and 2010 worked in various positions for BTR Automotive, Metzeler, Trelleborg, Xerium Technologies and IBP Group in locations in Europe, USA and Asia. Since 1999 he has worked in businesses owned by private equity with Metzeler belonging to CVC and Xerium Technologies an Apax portfolio business. His final executive position was as Group CEO for IBP Group (a Sun Capital Partner portfolio business) and since then has worked as an operating partner for Better Capital and currently has a portfolio of Non-executive appointments.
Burkhard Wittek, Non-Executive Chairman of IDS said: "Peter is a valuable addition to IDS' DNA in the area of business acumen with a focus on efficient processes and costs and on behalf of the Company I welcome him to the Board at this time."
A further announcement containing disclosures pursuant to Schedule Two paragraph (g) of the AIM Rules for Companies will be made shortly.
Immunodiagnostic Systems Holdings plc | Tel : +44 (0)191 5190660 |
Patricio Lacalle, Chief Executive Officer | |
Chris Yates, Group Finance Director
| |
Peel Hunt LLP | Tel : +44 (0)207 418 8900 |
James Steel | |
Clare Terlouw |